Menopause Treatment Market
Market Insights on Menopause Treatment covering sales outlook, demand forecast & up-to-date key trends
Menopause Treatment Market By Product, Route of Administration, Distribution Channel & Region | Forecast 2022 to 2032
Menopause Treatment Market Snapshot (2022 to 2032)
[272 Pages Report] The global menopause treatment market is expected to enjoy a valuation of US$ 13.3 Billion by the end of the year 2022, and further expand at a CAGR of 5.5% to reach a valuation of ~US$ 22.9 Billion by the year 2032. According to a recent study by Future Market Insights, hormone therapy, by product, is leading the market with a share of about 59.7% in the year 2021, within the global market.
Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2022 |
US$ 21.7 Billion |
|
Market Value 2032 |
US$ 22.9 Billion |
|
CAGR 2022-2032 |
5.6% |
|
Market Share of Top 5 Countries |
55.5% |
|
Key Market Players |
Eli Lilly and Company, Merck KGaA, Novartis AG, Bayer AG, Pfizer, Inc., Novo Nordisk, Ascend Therapeutics, Mylan N.V. [Viatris], Cipla, Inc., Glenmark Pharmaceuticals Ltd., MenoGeniX, Perrigo Pharma International D.A.C., Ausio Pharmaceuticals, LLC, EndoCeutics, Inc., and Radius Health, Inc. |
Menopause is a natural biological process due to the decline of reproductive hormones. This marks the end of the menstrual cycle in a woman’s life. It generally occurs at the age of 40s or 50s. Every woman experiences these menopause symptoms in a different way. Estrogen levels decrease throughout menopause. These signs and symptoms include abnormal menstrual cycles, night sweats, vaginal dryness, hot flashes, difficulty sleeping, mood swings, and others.
Hormone Replacement Therapy is the most successful treatment for menopause symptoms. Hormone replacement therapy (HRT), also known as menopausal hormone therapy and oestrogen replacement therapy, can address both growth hormone and thyroid hormone deficiencies. HRT replaces depleted hormone levels as menopausal women experience them.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Menopause Treatment Market from 2017 to 2021 Vs Market Outlook for 2022 to 2032
The global menopause market is valued at US$ 17.2 Billion out of which the menopause treatment market consists of a share of 73.5%.
The menopause market is not only about therapy but also menstrual wellness and care. A majority of supplements available provide wellness and care. Although over-the-counter medication holds a more significant chunk of the market due to its use in therapy.
The global postmenopausal female population is increasing. According to the World Health Organization 2022, women over the age of 50 and more accounted for 26% of all women and girls worldwide in 2021. This was an increase from 22% ten years ago.
Women are also living longer lives. On average, a woman turning 60 in 2019 can expect to live another 21 years.
A majority of the female population faces menopause, osteoporosis, growth hormone deficiency, thyroid, and cancer. Hot flashes, vaginal dryness, mood changes, night sweats, and bone loss are similar patterns and trends observed. Early menopause and hysterectomy are also procedures or behaviors that contribute to the event. This creates a scope for the manufacturers to work on better drug formulations, which can address the problems of patients suffering from menopause along with underlying chronic diseases.
Evenity (romosozumab-aqqg) has been given approval by the U.S. Food and Drug Administration to manage osteoporosis among postmenopausal women who are at severe risk of breaking a bone (fracture). These are women who have a record of osteoporotic fractures, have several fracture risk factors, or have tried and failed to respond to various osteoporosis treatments. Women at risk of osteoporosis are benefitted from such therapies, and companies come up with novel products and regulatory approvals on drugs. Thus, the market will gain traction, as more post-menopausal women will adopt these therapies.
Smoking, side effects of chemotherapy or radiation, ovarian cyst, and unhealthy lifestyle are assumptions that create and trigger the associated symptoms of menopause. Disruptive technology in drug development and delivery in menopause treatment, with therapy affordability, is expected to spur industry growth.
Thus, owing to the aforementioned factors, the global menopause treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2022 to 2032.
What are the Key Opportunities for the Manufacturers operating in the Menopause Treatment Market?
An increase in the number of menopausal drugs in the drug development pipeline of various vital manufacturers is one of the biggest opportunities for the growth of the menopause treatment market. This also includes specific and innovative drugs, which focus on reducing side effects and providing better efficacy.
For instance, Fuji Pharma Co., Ltd. has a natural progesterone drug (FSN-011-01) in its pipeline and has submitted an application for marketing approval to the Ministry of Health, Labour and Welfare, Japan.
The first and only body-identical hormone replacement therapy (HRT) for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least a year since their last period, Bijuva, also known as Bijuve in the UK, which includes estradiol and progesterone in a single daily oral capsule.
The presence of natural and herbal treatment is also an option that makes women feel secure if the traditional treatment method fails.
Government initiatives to create awareness about women’s health, especially menopause, could be an opportunity to grow the menopause treatment market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Demand for Menopause Treatment?
The risks associated with menopausal hormone therapies can hamper the menopause treatment market growth. Menopausal hormone therapy or postmenopausal hormone therapy involves treatment with either estrogen alone or estrogen in combination with progestin.
Hormone therapy carries various hazards, including the possibility of stroke, blood clots, heart problems, and breast cancer, according to the FDA. The FDA also recommends that hormone therapy be taken at the lowest effective dose for the shortest amount of time.
Strict regulatory approvals can be a restraining factor for the menopausal drugs market. The approval process for the drugs is quite time-consuming and strict due to the safety and efficacy profiles associated with the drugs.
Country-wise Insights
What Makes the US a Highly Lucrative Market for Menopause Treatment?
The US dominates the global menopause treatment market with a total global market share of about 18.7% in 2021 and is expected to continue to experience the same growth throughout the forecast period with a CAGR growth rate of nearly 5.8%.
Due to a stronger emphasis on research and development, the American pharmaceutical industry has advanced significantly during the past few decades. The advanced medical environment in the country has resulted in the world's lowest cancer mortality rates, a life expectancy for people over 80 that is actually higher compared to other regions, and reduced heart attack and stroke death rates than those in similar countries. This can fundamentally be attributed to the country’s economy.
According to the American Medical Association 2021 study, the average age of natural menopause grew by 1.5 years over the previous six decades, whereas the average reproductive life duration increased by 2.1 years.
As a result of the aforementioned causes, demand for menopause treatment will continue to rise in the United States, boosting the overall value of the menopause treatment market.
What is the Outlook of China in the Menopause Treatment Market?
China is one of the leading manufacturers in the menopause treatment market. China held a global market share of 11.4% and is anticipated to grow at a rapid pace over the forecast period due to rising healthcare facilities in the region along with prominent manufacturers.
China is one of the most densely inhabited countries. The growing elderly population and the need for healthcare services present an opportunity for the menopause treatment market to flourish in countries such as China.
The cost of production is lower in China. Multinational corporations are eyeing China for the manufacturing benefits it provides, and they are collaborating with the Chinese raw material manufacturer to compete with the primary competitors.
What Makes India a Large Market for Menopause Treatment?
India is set to exhibit growth at a CAGR of nearly 5.9% in the global menopause treatment market during the forecast period. The establishment of society and institutes focusing on creating general awareness and eliminating taboos related to menopause is growing in India. According to National Family Health Survey 2021, in India, 35.3% of menopausal women experienced induced menopause.
Contract manufacturing organizations (CMO) and pharmaceutical industries in India have recently drawn significant investment from global private equity investors owing to favorable government policies and a growing generic pharmaceuticals market. More companies are interested and are investing in CMOs as India displays strides in technology, development, infrastructure, and product innovations.
The market is also being driven by the nation's access to manufacturing facilities and strong levels of Research and Development activity. Researchers are working together to develop effective, multipurpose menopause treatment.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which Menopause Treatment Product is Driving Market Growth?
Hormone therapy is expected to present high growth at a CAGR of 5.6% by the end of the forecast period, holding a market share of about 59.7% in the global market in 2021. The most effective and widely accepted method of treating menopausal heat flashes is estrogen medication and thus accelerating market growth. Hormone therapy is widely accepted for a long period of time because of its efficiency and improvement that it brings to women’s health.
Which Route of Administration is dominating the Menopause Treatment Market Globally?
The oral route of administration is widely accepted and used in the menopause treatment market and held a market share of around 64.0% in 2021. This segment is further expected to grow at a CAGR of 5.7% over the forecast duration. Oral drugs are one of the easiest, most affordable, most durable, and most portable. The contamination rate is also the least. This makes the oral route of administration more lucrative. The oral mode of administration is the most accessible, cost-effective, and widely used mode of medication administration.
Which Distribution Channel Benefits the Most from the Sales of Menopause Treatment Products Globally?
Retail sales held the highest market share with a revenue of around US$ 5.6 Billion during the year 2021. The easy availability and additional benefits such as ease of locations and delivery of medications make retail sales the most lucrative segment of the overall menopause treatment market. Moreover, greater ease of accessibility to hormone therapies introduces greater adoption of menopause treatment, thus propelling market sales.
Competitive Landscape
The total market is fragmented, with large and notable rivals in the menopausal treatment production sphere. These companies are employing techniques such as mergers and acquisitions, partnerships and collaborations, and new product offerings to match consumer demand and expand their client base.
Instances of key developmental strategies by the industry players in the menopause treatment market are given below:
- In 2017, Mylan N.V. US introduced Estradiol Vaginal Cream USP, 0.01%, the very first generic form of Allergan's Estrace® cream. The FDA granted Mylan final approval for its abbreviated new drug application (ANDA) for this medicine, which was indicated for the treatment of vulvar and vaginal atrophy.
- Myovant Sciences and Pfizer Inc. confirmed in May 2021 that the US Food and Drug Administration (FDA) had authorized MYFEMBREE®, the first once-daily medication for excessive menstrual bleeding linked with uterine fibroids in premenopausal women.
Similarly, recent developments related to companies manufacturing menopause treatment products, have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope as per Menopause Treatment Industry Analysis
|
Attribute |
Details |
|
Historical Data Available for |
2017 to 2021 |
|
Forecast Period |
2022 to 2032 |
|
Market Analysis |
US$ Million for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
|
Key Market Segments Covered |
Product, Route of Administration, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered in Menopause Treatment Industry Research
By Product:
- Hormone Therapy
- Combination
- Tibolone
- Progestin-Only Medicines
- Estrogen-Only Medicines
- Non-Hormonal Therapy
- Gabapentinoids
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Others
By Route of Administration:
- Topical
- Injectable
- Oral
By Distribution Channel:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Supermarkets/ Hypermarkets
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global menopause treatment market is estimated to be worth US$ 13.3 Billion in 2022 and is set to expand 1.7X over the next ten years.
The menopause treatment market is expected to reach US$ 22.9 Bn by the end of 2032.
An increased focus on reducing the adverse effects of therapy, novel drug launches, and government campaigns providing general awareness about menopause, are some of the key trends in this menopause treatment market.
The US, China, India, Japan, and Malaysia are the top five countries, which are expected to drive demand in the menopause treatment market.
The North American region is set to expand at a CAGR of 5.8% and holds a market share of about 21.4% by value in 2021 in the global menopause treatment market
Demand for menopause treatment in Europe is expected to register substantial growth as it generated nearly US$ 2.1 Billion in revenue in the global menopause treatment market in 2021.
China accounts for about 11.4% of the market share in 2021 in the global menopause treatment market.
East Asia region is growing with a CAGR of 5.7% with a market share of 22.2% in the global menopause treatment market in 2021.
India's menopause treatment market is expected to expand at a 5.9% CAGR over the forecast period.
Eli Lilly and Company, Merck KGaA, Novartis AG, Bayer AG, Pfizer, Inc., Novo Nordisk , Ascend Therapeutics, Mylan N.V. [Viatris], Cipla, Inc., Glenmark Pharmaceuticals Ltd., MenoGeniX, Perrigo Pharma International D.A.C., Ausio Pharmaceuticals, LLC, Endo Ceutics, Inc., and Radius Health, Inc. are the key players in the menopause treatment industry.
Table of Content
1. Executive Summary | Menopause Treatment Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development and Innovation Trends
4. Key Success Factors
4.1. Product Adoption Analysis
4.2. Recent Product Launches and Approvals
4.3. Regulatory Scenario
4.4. PESTLE Analysis
4.5. Porter’s Analysis
4.6. Supply Chain Analysis
4.7. Key Strategies Adopted By Manufacturers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.1.3. Global Menopause Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. R&D Expenditure of Pharmaceutical Companies
5.2.2. Improvement in Healthcare Infrastructure
5.2.3. Incidence of Vasomotor Symptoms
5.2.4. Increase in Ageing Population
5.2.5. Women's Health Campaigns
5.2.6. Government Funding
5.2.7. Product Recall
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Route of Administration
6.1.3. By Distribution Channel
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis, By Product, 2017 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Product, 2022 to 2032
8.3.1. Hormone Therapy
8.3.1.1. Combination
8.3.1.2. Tibolone
8.3.1.3. Progestin-Only Medicines
8.3.1.4. Estrogen-Only Medicines
8.3.2. Non-Hormonal Therapy
8.3.2.1. Gabapentinoids
8.3.2.2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
8.3.2.3. Selective Serotonin Reuptake Inhibitors (SSRI)
8.3.2.4. Others
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis, By Route of Administration, 2017 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Route of Administration, 2022 to 2032
9.3.1. Topical
9.3.2. Injectable
9.3.3. Oral
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Market Analysis By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis, By Distribution Channel, 2017 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Distribution Channel, 2022 to 2032
10.3.1. Institutional Sales
10.3.1.1. Hospitals
10.3.1.2. Specialty Clinics
10.3.2. Retail Sales
10.3.2.1. Retail Pharmacies
10.3.2.2. Drug Stores
10.3.2.3. Supermarkets/ Hypermarkets
10.3.3. Online Sales
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Market Analysis By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis, By Region, 2017 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis Forecast, By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2017 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. The US
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Route of Administration
12.4.4. By Distribution Channel
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
12.7. Key Market Trends
12.8. Country-Level Analysis & Forecast
12.8.1. The US Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Route of Administration
12.8.1.2.3. By Distribution Channel
12.8.2. Canada Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Route of Administration
12.8.2.2.3. By Distribution Channel
13. Latin America Market Analysis
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis & Forecast By Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Argentina
13.3.1.3. Mexico
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Route of Administration
13.4.4. By Distribution Channel
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Market Trends
13.8. Country-Level Analysis & Forecast
13.8.1. Brazil Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Route of Administration
13.8.1.2.3. By Distribution Channel
13.8.2. Argentina Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Route of Administration
13.8.2.2.3. By Distribution Channel
13.8.3. Mexico Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Route of Administration
13.8.3.2.3. By Distribution Channel
14. Europe Market Analysis
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. The UK
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Route of Administration
14.4.4. By Distribution Channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Market Trends
14.8. Country-Level Analysis & Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Route of Administration
14.8.1.2.3. By Distribution Channel
14.8.2. France Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Route of Administration
14.8.2.2.3. By Distribution Channel
14.8.3. Italy Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Route of Administration
14.8.3.2.3. By Distribution Channel
14.8.4. Spain Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Route of Administration
14.8.4.2.3. By Distribution Channel
14.8.5. The UK Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Route of Administration
14.8.5.2.3. By Distribution Channel
14.8.6. BENULUX Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Route of Administration
14.8.6.2.3. By Distribution Channel
14.8.7. Russia Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Route of Administration
14.8.7.2.3. By Distribution Channel
15. South Asia Market Analysis
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Route of Administration
15.4.4. By Distribution Channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Market Trends
15.8. Country-Level Analysis & Forecast
15.8.1. India Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Route of Administration
15.8.1.2.3. By Distribution Channel
15.8.2. Indonesia Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Route of Administration
15.8.2.2.3. By Distribution Channel
15.8.3. Malaysia Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Route of Administration
15.8.3.2.3. By Distribution Channel
15.8.4. Thailand Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Route of Administration
15.8.4.2.3. By Distribution Channel
16. East Asia Market Analysis
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Route of Administration
16.4.4. By Distribution Channel
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Market Trends
16.8. Country-Level Analysis & Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Route of Administration
16.8.1.2.3. By Distribution Channel
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Route of Administration
16.8.2.2.3. By Distribution Channel
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Route of Administration
16.8.3.2.3. By Distribution Channel
17. Oceania Market Analysis
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Route of Administration
17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Market Trends
17.8. Country-Level Analysis & Forecast
17.8.1. Australia Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Route of Administration
17.8.1.2.3. By Distribution Channel
17.8.2. New Zealand Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Route of Administration
17.8.2.2.3. By Distribution Channel
18. Middle East and Africa (MEA) Market Analysis
18.1. Introduction
18.2. Historical Market Size (US$ Million Trend Analysis By Market Taxonomy, 2017 to 2021
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. North Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Route of Administration
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Route of Administration
18.4.4. By Distribution Channel
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Market Trends
18.8. Country-Level Analysis & Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Route of Administration
18.8.1.2.3. By Distribution Channel
18.8.2. Turkey Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Route of Administration
18.8.2.2.3. By Distribution Channel
18.8.3. South Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Route of Administration
18.8.3.2.3. By Distribution Channel
18.8.4. North Africa Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Route of Administration
18.8.4.2.3. By Distribution Channel
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. By Regional Footprint of Players
19.3.2. By Product Footprint of Players
19.3.3. By Channel Footprint of Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Eli Lilly and Company
20.3.1.1. Company Overview
20.3.1.2. Product Portfolio
20.3.1.3. Product Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Key Developments
20.3.1.7. Strategy Overview
20.3.1.7.1. Product Strategy
20.3.1.7.2. Channel Strategy
20.3.1.7.3. Marketing Strategy
20.3.2. Merck KGaA
20.3.2.1. Company Overview
20.3.2.2. Product Portfolio
20.3.2.3. Product Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Key Developments
20.3.2.7. Strategy Overview
20.3.2.7.1. Product Strategy
20.3.2.7.2. Channel Strategy
20.3.2.7.3. Marketing Strategy
20.3.3. Novartis AG
20.3.3.1. Company Overview
20.3.3.2. Product Portfolio
20.3.3.3. Product Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Key Developments
20.3.3.7. Strategy Overview
20.3.3.7.1. Product Strategy
20.3.3.7.2. Channel Strategy
20.3.3.7.3. Marketing Strategy
20.3.4. Bayer’s AG
20.3.4.1. Company Overview
20.3.4.2. Product Portfolio
20.3.4.3. Product Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Key Developments
20.3.4.7. Strategy Overview
20.3.4.7.1. Product Strategy
20.3.4.7.2. Channel Strategy
20.3.4.7.3. Marketing Strategy
20.3.5. Pfizer, Inc.
20.3.5.1. Company Overview
20.3.5.2. Product Portfolio
20.3.5.3. Product Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Key Developments
20.3.5.7. Strategy Overview
20.3.5.7.1. Product Strategy
20.3.5.7.2. Channel Strategy
20.3.5.7.3. Marketing Strategy
20.3.6. Novo Nordisk
20.3.6.1. Company Overview
20.3.6.2. Product Portfolio
20.3.6.3. Product Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Key Developments
20.3.6.7. Strategy Overview
20.3.6.7.1. Product Strategy
20.3.6.7.2. Channel Strategy
20.3.6.7.3. Marketing Strategy
20.3.7. Ascend Therapeutics
20.3.7.1. Company Overview
20.3.7.2. Product Portfolio
20.3.7.3. Product Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Key Developments
20.3.7.7. Strategy Overview
20.3.7.7.1. Product Strategy
20.3.7.7.2. Channel Strategy
20.3.7.7.3. Marketing Strategy
20.3.8. Mylan N.V. [Viatris]
20.3.8.1. Company Overview
20.3.8.2. Product Portfolio
20.3.8.3. Product Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Key Developments
20.3.8.7. Strategy Overview
20.3.8.7.1. Product Strategy
20.3.8.7.2. Channel Strategy
20.3.8.7.3. Marketing Strategy
20.3.9. Cipla, Inc.
20.3.9.1. Company Overview
20.3.9.2. Product Portfolio
20.3.9.3. Product Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Key Developments
20.3.9.7. Strategy Overview
20.3.9.7.1. Product Strategy
20.3.9.7.2. Channel Strategy
20.3.9.7.3. Marketing Strategy
20.3.10. Glenmark Pharmaceuticals Ltd.
20.3.10.1. Company Overview
20.3.10.2. Product Portfolio
20.3.10.3. Product Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Key Developments
20.3.10.7. Strategy Overview
20.3.10.7.1. Product Strategy
20.3.10.7.2. Channel Strategy
20.3.10.7.3. Marketing Strategy
20.3.11. MenoGeniX
20.3.11.1. Company Overview
20.3.11.2. Product Portfolio
20.3.11.3. Product Footprint
20.3.11.4. Key Financials
20.3.11.5. SWOT Analysis
20.3.11.6. Key Developments
20.3.11.7. Strategy Overview
20.3.11.7.1. Product Strategy
20.3.11.7.2. Channel Strategy
20.3.11.7.3. Marketing Strategy
20.3.12. Perrigo Pharma International D.A.C.
20.3.12.1. Company Overview
20.3.12.2. Product Portfolio
20.3.12.3. Product Footprint
20.3.12.4. Key Financials
20.3.12.5. SWOT Analysis
20.3.12.6. Key Developments
20.3.12.7. Strategy Overview
20.3.12.7.1. Product Strategy
20.3.12.7.2. Channel Strategy
20.3.12.7.3. Marketing Strategy
20.3.13. Ausio Pharmaceuticals, LLC
20.3.13.1. Company Overview
20.3.13.2. Product Portfolio
20.3.13.3. Product Footprint
20.3.13.4. Key Financials
20.3.13.5. SWOT Analysis
20.3.13.6. Key Developments
20.3.13.7. Strategy Overview
20.3.13.7.1. Product Strategy
20.3.13.7.2. Channel Strategy
20.3.13.7.3. Marketing Strategy
20.3.14. EndoCeutics, Inc.
20.3.14.1. Company Overview
20.3.14.2. Product Portfolio
20.3.14.3. Product Footprint
20.3.14.4. Key Financials
20.3.14.5. SWOT Analysis
20.3.14.6. Key Developments
20.3.14.7. Strategy Overview
20.3.14.7.1. Product Strategy
20.3.14.7.2. Channel Strategy
20.3.14.7.3. Marketing Strategy
20.3.15. Radius Health, Inc.
20.3.15.1. Company Overview
20.3.15.2. Product Portfolio
20.3.15.3. Product Footprint
20.3.15.4. Key Financials
20.3.15.5. SWOT Analysis
20.3.15.6. Key Developments
20.3.15.7. Strategy Overview
20.3.15.7.1. Product Strategy
20.3.15.7.2. Channel Strategy
20.3.15.7.3. Marketing Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 02: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration
Table 03: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 04: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
Table 05: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 07: North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration
Table 08: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 09: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 10: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 11: Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration
Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 13: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 14: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 15: Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration
Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 17: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 18: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 19: East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration
Table 20: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 21: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 22: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 23: South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration
Table 24: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 25: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 26: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 27: Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Route of Administration
Table 28: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Table 29: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
Table 30: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
Table 31: Middle East & Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 by Route of Administration
Table 32: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value Analysis, 2017 to 2021
Figure 02: Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021 to 2032
Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, By Product
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Product
Figure 06: Global Market Attractiveness Analysis 2022 to 2032, By Product
Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, By Route of Administration
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Route of Administration
Figure 09: Global Market Attractiveness Analysis 2022 to 2032, By Route of Administration
Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, By Distribution Channel
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Distribution Channel
Figure 12: Global Market Attractiveness Analysis 2022 to 2032, By Distribution Channel
Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, By Region
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Region
Figure 15: Global Market Attractiveness Analysis 2022 to 2032, By Region
Figure 16: North America Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 17: North America Market Y-o-Y Analysis, 2022 to 2032
Figure 18: North America Market Value Analysis, 2017 to 2021
Figure 19: North America Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 20: North America Market Value Share, By Product (2022 E)
Figure 21: North America Market Value Share, By Route of Administration (2022 E)
Figure 22: North America Market Value Share, By Distribution Channel (2022 E)
Figure 23: North America Market Value Share, By Country (2022 E)
Figure 24: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 25: North America Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 26: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 27: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 28: US Market Value Proportion Analysis, 2021
Figure 29: US Market Share Analysis (%) By Product, 2021 to 2032
Figure 30: US Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 31: US Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 32: Global Vs. US Growth Comparison
Figure 33: Canada Market Value Proportion Analysis, 2021
Figure 34: Canada Market Share Analysis (%) By Product, 2021 to 2032
Figure 35: Canada Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 36: Canada Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 37: Global Vs. Canada. Growth Comparison
Figure 38: Latin America Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 39: Latin America Market Y-o-Y Analysis, 2022 to 2032
Figure 40: Latin America Market Value Analysis, 2017 to 2021
Figure 41: Latin America Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 42: Latin America Market Value Share, By Product (2022 E)
Figure 43: Latin America Market Value Share, By Route of Administration (2022 E)
Figure 44: Latin America Market Value Share, By Distribution Channel (2022 E)
Figure 45: Latin America Market Value Share, By Country (2022 E)
Figure 46: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 47: Latin America Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 49: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 50: Mexico Market Value Proportion Analysis, 2021
Figure 51: Mexico Market Share Analysis (%) By Product, 2021 to 2032
Figure 52: Mexico Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 53: Mexico Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 54: Global Vs Mexico Growth Comparison
Figure 55: Brazil Market Value Proportion Analysis, 2021
Figure 56: Brazil Market Share Analysis (%) By Product, 2021 to 2032
Figure 57: Brazil Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 58: Brazil Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 59: Global Vs. Brazil. Growth Comparison
Figure 60: Argentina Market Value Proportion Analysis, 2021
Figure 61: Argentina Market Share Analysis (%) By Product, 2021 to 2032
Figure 62: Argentina Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 63: Argentina Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 64: Global Vs Argentina Growth Comparison
Figure 65: Europe Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 66: Europe Market Y-o-Y Analysis, 2022 to 2032
Figure 67: Europe Market Value Analysis, 2017 to 2021
Figure 68: Europe Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 69: Europe Market Value Share, By Product (2022 E)
Figure 70: Europe Market Value Share, By Route of Administration (2022 E)
Figure 71: Europe Market Value Share, By Distribution Channel (2022 E)
Figure 72: Europe Market Value Share, By Country (2022 E)
Figure 73: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 74: Europe Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 75: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 76: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 77: UK. Market Value Proportion Analysis, 2021
Figure 78: UK. Market Share Analysis (%) By Product, 2021 to 2032
Figure 79: UK. Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 80: UK. Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 81: Global Vs. UK Growth Comparison
Figure 82: Germany Market Value Proportion Analysis, 2021
Figure 83: Germany Market Share Analysis (%) By Product, 2021 to 2032
Figure 84: Germany Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 85: Germany Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 86: Global Vs. Germany Growth Comparison
Figure 87: Italy Market Value Proportion Analysis, 2021
Figure 88: Italy Market Share Analysis (%) By Product, 2021 to 2032
Figure 89: Italy Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 90: Italy Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 91: Global Vs. Italy Growth Comparison
Figure 92: France Market Value Proportion Analysis, 2021
Figure 93: France Market Share Analysis (%) By Product, 2021 to 2032
Figure 94: France Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 95: France Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 96: Global Vs France Growth Comparison
Figure 97: Spain Market Value Proportion Analysis, 2021
Figure 98: Spain Market Share Analysis (%) By Product, 2021 to 2032
Figure 99: Spain Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 100: Spain Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 101: Global Vs Spain Growth Comparison
Figure 102: Russia Market Value Proportion Analysis, 2021
Figure 103: Russia Market Share Analysis (%) By Product, 2021 to 2032
Figure 104: Russia Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 105: Russia Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 106: Global Vs Russia Growth Comparison
Figure 107: BENELUX Market Value Proportion Analysis, 2021
Figure 108: BENELUX Market Share Analysis (%) By Product, 2021 to 2032
Figure 109: BENELUX Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 110: BENELUX Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 111: Global Vs BENELUX Growth Comparison
Figure 112: East Asia Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 113: East Asia Market Y-o-Y Analysis, 2022 to 2032
Figure 114: East Asia Market Value Analysis, 2017 to 2021
Figure 115: East Asia Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 116: East Asia Market Value Share, By Product (2022 E)
Figure 117: East Asia Market Value Share, By Route of Administration (2022 E)
Figure 118: East Asia Market Value Share, By Distribution Channel (2022 E)
Figure 119: East Asia Market Value Share, By Country (2022 E)
Figure 120: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 121: East Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 122: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 123: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 124: China Market Value Proportion Analysis, 2021
Figure 125: China Market Share Analysis (%) By Product, 2021 to 2032
Figure 126: China Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 127: China Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 128: Global Vs. China Growth Comparison
Figure 129: Japan Market Value Proportion Analysis, 2021
Figure 130: Japan Market Share Analysis (%) By Product, 2021 to 2032
Figure 131: Japan Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 132: Japan Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 133: Global Vs. Japan Growth Comparison
Figure 134: South Korea Market Value Proportion Analysis, 2021
Figure 135: South Korea Market Share Analysis (%) By Product, 2021 to 2032
Figure 136: South Korea Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 137: South Korea Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 138: Global Vs South Korea Growth Comparison
Figure 139: South Asia Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 140: South Asia Market Y-o-Y Analysis, 2022 to 2032
Figure 141: South Asia Market Value Analysis, 2017 to 2021
Figure 142: South Asia Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 143: South Asia Market Value Share, By Product (2022 E)
Figure 144: South Asia Market Value Share, By Route of Administration (2022 E)
Figure 145: South Asia Market Value Share, By Distribution Channel (2022 E)
Figure 146: South Asia Market Value Share, By Country (2022 E)
Figure 147: South Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 148: South Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 149: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 150: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 151: India Market Value Proportion Analysis, 2021
Figure 152: India Market Share Analysis (%) By Product, 2021 to 2032
Figure 153: India Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 154: India Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 155: Global Vs. India Growth Comparison
Figure 156: Indonesia Market Value Proportion Analysis, 2021
Figure 157: Indonesia Market Share Analysis (%) By Product, 2021 to 2032
Figure 158: Indonesia Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 159: Indonesia Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 160: Global Vs. Indonesia Growth Comparison
Figure 161: Malaysia Market Value Proportion Analysis, 2021
Figure 162: Malaysia Market Share Analysis (%) By Product, 2021 to 2032
Figure 163: Malaysia Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 164: Malaysia Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 165: Global Vs. Malaysia Growth Comparison
Figure 166: Thailand Market Value Proportion Analysis, 2021
Figure 167: Thailand Market Share Analysis (%) By Product, 2021 to 2032
Figure 168: Thailand Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 169: Thailand Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 170: Global Vs. Thailand Growth Comparison
Figure 171: Oceania Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 172: Oceania Market Y-o-Y Analysis, 2022 to 2032
Figure 173: Oceania Market Value Analysis, 2017 to 2021
Figure 174: Oceania Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 175: Oceania Market Value Share, By Product (2022 E)
Figure 176: Oceania Market Value Share, By Route of Administration (2022 E)
Figure 177: Oceania Market Value Share, By Distribution Channel (2022 E)
Figure 178: Oceania Market Value Share, By Country (2022 E)
Figure 179: Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 180: Oceania Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 181: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 182: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 183: Australia Market Value Proportion Analysis, 2021
Figure 184: Australia Market Share Analysis (%) By Product, 2021 to 2032
Figure 185: Australia Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 186: Australia Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 187: Global Vs. Australia Growth Comparison
Figure 188: New Zealand Market Value Proportion Analysis, 2021
Figure 189: New Zealand Market Share Analysis (%) By Product, 2021 to 2032
Figure 190: New Zealand Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 191: New Zealand Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 192: Global Vs New Zealand Growth Comparison
Figure 193: Middle East & Africa Market Size (US$ Million) Analysis, 2022E & 2032F
Figure 194: Middle East & Africa Market Y-o-Y Analysis, 2022 to 2032
Figure 195: Middle East & Africa Market Value Analysis, 2017 to 2021
Figure 196: Middle East & Africa Market Forecast & Y-o-Y growth, 2022 to 2032
Figure 197: Middle East & Africa Market Value Share, By Product (2022 E)
Figure 198: Middle East & Africa Market Value Share, By Route of Administration (2022 E)
Figure 199: Middle East & Africa Market Value Share, By Distribution Channel (2022 E)
Figure 200: Middle East & Africa Market Value Share, By Country (2022 E)
Figure 201: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032
Figure 202: Middle East & Africa Market Attractiveness Analysis by Route of Administration, 2022 to 2032
Figure 203: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 204: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 205: GCC Countries Market Value Proportion Analysis, 2021
Figure 206: GCC Countries Market Share Analysis (%) By Product, 2021 to 2032
Figure 207: GCC Countries Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 208: GCC Countries Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 209: Global Vs GCC Countries Growth Comparison
Figure 210: Turkey Market Value Proportion Analysis, 2021
Figure 211: Turkey Market Share Analysis (%) By Product, 2021 to 2032
Figure 212: Turkey Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 213: Turkey Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 214: Global Vs. Turkey Growth Comparison
Figure 215: South Africa Market Value Proportion Analysis, 2021
Figure 216: South Africa Market Share Analysis (%) By Product, 2021 to 2032
Figure 217: South Africa Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 218: South Africa Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 219: Global Vs. South Africa Growth Comparison
Figure 220: North Africa Market Value Proportion Analysis, 2021
Figure 221: North Africa Market Share Analysis (%) By Product, 2021 to 2032
Figure 222: North Africa Market Share Analysis (%) By Route of Administration, 2021 to 2032
Figure 223: North Africa Market Share Analysis (%) By Distribution Channel, 2021 to 2032
Figure 224: Global Vs North Africa Growth Comparison
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
